Large gap with delayed quotes
Analysis date: 18.09.2026
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 07.08.2026.
Quality
Very strong
Very strong
Four stars since 01.09.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 01.09.2026 at a price of 2147.00.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 23.06.2026.
4wk Rel Perf
9.94%
9.94%
The four-week dividend-adjusted overperformance versus STOXX600 is 9.94%.
Risk
Low
Low
The stock has been on the low-sensitivity level since 15.09.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.03%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.67%.
Mkt Cap in $bn
20.71
20.71
With a market capitalization >$8bn, GENMAB is considered a large-cap stock.
G/PE Ratio
1.56
1.56
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
12.96
12.96
The estimated PE is for the year 2028.
LT Growth
20.20%
20.20%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
20
20
Over the last seven weeks, an average of 20 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
113
113
For 1% of index variation, the stock varies on average by 1.13%.
Correlation
0.41
0.41
41.20% of stock movements are explained by index variations.
Value at Risk
271.20
271.20
The value at risk is estimated at DKK 271.20. The risk is therefore 12.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004